Authors

2021 Acne Updates: New Drugs and Research

A presentation from Maui Derm Live 2021 featured insights on new drugs and data in acne.

Q&A: Diagnostic and Therapeutic Pearls for Pediatric Dermatology

Mancini discusses his SPD 2024 lecture, emphasizing off-label treatments, surrogate diagnostic markers, simpler therapies, and the importance of empathy and education.

Rashmi Sarkar, MD, FAMS: Vitiligo and Stigma

Sarkar spoke with Dermatology Times after the ReV conference to discuss her session on vitiligo stigma.

Cyltezo Biosimilar Launches Today in the US

Boehringer Ingelheim’s Cyltezo is the first and only FDA-approved interchangeable biosimilar to adalimumab.

The JAK Inhibitor Pipeline Builds in Dermatology

Eight JAK inhibitors are approved by the FDA to treat autoimmune, inflammatory, and allergic conditions.

Advances in Treatment Resistant Port-Wine Birthmarks: Emerging Therapies and Future Directions

Expect exciting news in the treatment of port-wine birthmarks, Kristen Marie Kelly, MD, told AAD Annual Meeting attendees.

CBP/β-catenin Antagonists: A Safe and Novel Approach for Skin Rejuvenation and Aging

Take a look at this overview of the top 5 considerations to show how CBP/β-catenin antagonists can be utilized for skin rejuvenation and anti-aging by enhancing Wnt/p300/β-catenin transcription.

Further Research Needed to Study Link Between AD and ADHD

Researchers found an association between ADHD and three inflammatory conditions—atopic dermatitis, otitis media, and herpes simplex infection.

Nivolumab Plus Talazoparib Does Not Induce Responses in Heavily Pretreated Melanoma

Nivolumab plus talazoparib did not produce RECIST-based tumor responses in heavily pretreated patients with unresectable or metastatic melanoma.

Looking Ahead to the 2023 ACMS Meeting

The ACMS president and scientific program chair share opportunities to discover innovations in Mohs surgery during this weekend’s meeting.

Gut Microbiome Can Affect Radiation Cancer Treatment

The overgrowth of fungi could cause the immune system to stop fighting cancer, according to a study.

Hands-on Workshop Empowers Clinicians in Cosmetic Dermatology

Robin Siperstein, MD, FAAD, shares practical tips in cosmetic dermatology at the 2024 SDPA Annual Summer Dermatology Meeting.

Advancing Aesthetics: Innovations, Trends, and Patient-Centric Strategies in the Era of Weight Loss Medications

Discover insights from Gerry Muhle and Michael Somenek, MD, on regenerative aesthetics, weight-loss impacts, and trends shaping facial rejuvenation.

Addressing Quality of Life Specifics Associated With Atopic Dermatitis and Skin of Color

Zakiya Pressley Rice, MD, took a deep dive into how atopic dermatitis severity and increased rates of grade school absenteeism affect patients with skin of color during a recent Masterclasses in Dermatology meeting.

Dermatologic differences in a diverse population

Understanding the difference in biology and clinical presentations of cutaneous conditions in different skin types is critical for health care professionals to treat a diverse population.

Lloyd Miller, MD, PhD: Delving Into JNJ-2113 Data for Plaque Psoriasis

Miller, Vice President, Immunodermatology Disease Area Leader, Johnson & Johnson, spoke with Dermatology Times about recently published data supporting JNJ-2113's potential in this indication.

Approaching Nonsegmental Vitiligo with a Focus on the Immune-Mediated Aspects of the Disease and a New Treatment Option to Consider

The Importance of Collaboration Between Mohs Surgeons and Urologists

Caleb Kovell, MD and Junqian Zhang, MD demonstrated how teaming up increases the likelihood for positive patient outcomes in Mohs cases on the genitalia and perianal region.

Frontline Forum Part 4: Improving Basal Cell Carcinoma Management

In the final part of this Frontline Forum series, Brent Moody, MD; Sarah Arron, MD, PhD; Justine Cohen, DO; Emily Ruiz, MD, MPH; and Todd Schlesinger, MD, review 4 real-world clinical cases of BCC and the treatments they utilized.

SFA-002 Shows Promise in Early Clinical Trial Psoriasis Cohorts

Stefan Weiss, MD, MBA, explains next steps for the oral treatment after the completion of phase 1b enrollment.

SPROUT Trial Highlights Benefits of Apremilast for Pediatric Psoriasis

The trial showcased the continued efficacy of apremilast, with 2-year data on the forefront.

An Increase in Skin Cancer Calls for an Increase in Treatment Options

To address the increased rates of skin cancer while keeping unique patient needs top of mind, there is a pressing need to increase options for treatment.

The Dx and Rx of Congenital Malalignment Syndrome in Children

Congenital malalignment syndrome is a nail disorder caused by the lateral rotation of the nail matrix.

Evan Rieder, MD: Equipping Patients With Tools for Skin Acceptance

Following this week's Science of Skin media roundtable hosted by AbbVie, panelist and dual-board certified dermatologist and psychiatrist Evan Rieder, MD, discusses the relationship between chronic skin conditions and mental health.

Tailoring Aesthetic Treatments for Patients With Skin of Color

Omer Ibrahim, MD, discusses the nuances of aesthetic procedures for patients with skin of color and the importance of tailored treatments, safety, and improved clinician education.

Select Medical Software Based on Your Practice’s Life Cycle Stage

Though providers probably can use any type of medical software, the financial resources they are able to invest in medical solutions differ significantly based on the type of practice.